Nesina Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Alogliptin (Primary) ; Biguanides
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Takeda
- 07 Jun 2017 Biomarkers information updated
- 25 Jan 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 30 Jul 2014 According to the ClinicalTrials.gov record, planned number of patients changed from 1000 to 1096.